Scaffold Technology Market Report 2024

This Scaffold Technology market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The scaffold technology market size has grown rapidly in recent years. It will grow from $1.37 billion in 2023 to $1.54 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. The growth during the historic period can be attributed to the increasing elderly population, a rise in chronic diseases, expansion of the biotechnology industry, heightened awareness of organ donation, and advancements in personalized medicine.

The scaffold technology market size is expected to see rapid growth in the next few years. It will grow to $2.47 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The anticipated growth during the forecast period can be attributed to the increasing demand for regenerative medicine, advancements in stem cell research, higher funding for life sciences, expanding applications in drug delivery, and government support and grants. Key trends include progress in tissue engineering, innovations in 3D printing, collaborations between academia and industry, technological advancements in biomaterials, and developments in bioprinting.

The increasing demand for body reconstruction procedures is expected to drive the growth of the scaffold technology market in the coming years. Body reconstruction procedures involve medical or surgical methods to repair, restore, or enhance damaged body structures to improve both function and appearance. This demand is fueled by factors such as higher rates of trauma, congenital abnormalities, and an increasing desire for aesthetic enhancements. Scaffold technology plays a key role in body reconstruction by providing a supportive structure that encourages tissue regeneration and repair, facilitating the effective rebuilding of damaged areas. For example, the Australian Institute of Health and Welfare, a government agency, reported that in 2022-23, 735,500 patients were admitted for surgery from public hospital elective surgery waiting lists, marking an 18% increase compared to 2021-22. As a result, the growing demand for body reconstruction procedures is driving the expansion of the scaffold technology market.

Key players in the scaffold technology market are focusing on developing advanced solutions, such as bioresorbable scaffolds, which provide temporary support for tissue growth. A bioresorbable scaffold is a biocompatible structure used in tissue engineering that gradually dissolves and is absorbed by the body while supporting tissue regeneration. For instance, in February 2024, BIOTRONIK, a Germany-based medical technology company, introduced the Freesolve™ Resorbable Magnesium Scaffold (RMS). This scaffold offers complete dissolution within 12 months and provides a viable alternative to drug-eluting stents (DES) for treating coronary artery lesions. Its biocompatible BIOmag magnesium alloy ensures temporary vessel support, improves patient outcomes, and provides superior safety, deliverability, and performance. The scaffold's various sizes and lengths allow for customized treatments, making it a prominent choice in cardiovascular interventions due to its natural compatibility with the human body.

In August 2022, CONMED Corporation, a US-based medical equipment manufacturer, acquired Biorez Inc. for an undisclosed amount. This acquisition enables CONMED to utilize Biorez’s advanced bioinductive collagen scaffold technology to enhance soft tissue healing in sports medicine. Biorez Inc. is a US-based manufacturer specializing in scaffolds for tissue engineering.

Major companies operating in the scaffold technology market are Johnson & Johnson, Medtronic Plc, Merck KGaA, Stryker Corporation, Corning Incorporated, Akzo Nobel N.V., Zimmer Biomet, Avantor Inc., Lonza Group AG, Smith & Nephew Plc, Bio-Rad Laboratories Inc., Tecan Trading AG, NuVasive Inc., Vericel Corporation, RTI Surgical Holdings Inc., Cellink AB, Thermo Fisher Scientific Inc., Cook Biotech Inc., PeproTech Inc., Collagen Matrix Inc., 3D Biotek LLC, Avacta Life Sciences Limited, Innovia Medical Inc., Molecular Matrix Inc., Organovo.

North America was the largest region in the scaffold technology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scaffold technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the scaffold technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Scaffold technology involves using engineered structures to support and guide the growth and development of new tissues or organs. These scaffolds are typically made from biocompatible materials and are designed to replicate the natural extracellular matrix (ECM) found in tissues. Scaffold technology is vital for creating tissue-engineered products in regenerative medicine, including repairing damaged tissues or organs and for drug testing and development.

The main types of scaffold technology include hydrogels, polymeric scaffolds, micropatterned surface microplates, and nanofiber-based scaffolds, among others. Hydrogels are water-absorbent materials that help maintain a moist environment, which is crucial for tissue growth and repair. These scaffolds are used in various fields, including neurology, urology, orthopedics, dental care, cardiology, vascular studies, oncology, dermatology, gastrointestinal and gynecological applications. They are utilized by biotechnology and pharmaceutical companies, research laboratories, hospitals, and diagnostic centers.

The scaffold technology market research report is one of a series of new reports that provides scaffold technology market statistics, including scaffold technology industry global market size, regional shares, competitors with a scaffold technology market share, detailed scaffold technology market segments, market trends and opportunities, and any further data you may need to thrive in the scaffold technology industry. This scaffold technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The scaffold technology market consists of sales of collagen scaffolds, synthetic polymer scaffolds, decellularized tissue scaffolds and bioactive scaffolds. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.